Dimethylformamide → HCID 71015337, compound
Reaction equation
[O:1]([C:8]1[CH:13]=[CH:12][C:11]([C:14]2[C:22]3[C:17](=[N:18][CH:19]=[N:20][C:21]=3[NH2:23])[N:16]([CH2:24][C@H:25]3[CH2:29][CH2:28][CH2:27][NH:26]3)[N:15]=2)=[CH:10][CH:9]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.C(N(CC)CC)C.N1(OC(N(C)C)=[N+](C)C)[C:41]2N=[CH:43][CH:44]=[CH:45][C:40]=2N=N1.[F:54][P-](F)(F)(F)(F)F.CN([CH:64]=[O:65])C>>[NH2:23][C:21]1[N:20]=[CH:19][N:18]=[C:17]2[N:16]([CH2:24][C@H:25]3[CH2:29][CH2:28][CH2:27][N:26]3[C:64](=[O:65])[C:41]([F:54])=[CH:40][CH:45]3[CH2:43][CH2:44]3)[N:15]=[C:14]([C:11]3[CH:10]=[CH:9][C:8]([O:1][C:2]4[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=4)=[CH:13][CH:12]=3)[C:22]=12Participants
Procedure
A mixture of (E/Z)-3-cyclopropyl-2-(trifluoromethyl)acrylic acid (30 mg, 0.17 mmol), (R)-3-(4-phenoxyphenyl)-1-(pyrrolidin-2-ylmethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine (158 mg, 0.52 mmol), Triethylamine (18.2 mg, 0.18 mmol) and DMF (3 mL) were stirred at room temperature for 10 min. O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium PF6 (69 mg, 0.18 mmol) was added and the reaction mixture was stirred for 2 h. The solvent was evaporated and the oil was worked up with ethylacetate and water. The organic layer was washed with brine and dried over MgSO4. Purification with column chromatography (SiO2, MeOH|DCM with gradient form 1% to 2% in total 500 mL) gave (R)-1-(2-((4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)pyrrolidin-1-yl)-3-cyclopropyl-2-fluoroprop-2-en-1-one. MS (pos. ion) m/z: 549 (M+1).
Workup
- stirringthe reaction mixture was stirred for 2 h
- customThe solvent was evaporated
- washThe organic layer was washed with brine
- dry with materialdried over MgSO4
- customPurification with column chromatography (SiO2, MeOH|DCM with gradient form 1% to 2% in total 500 mL)
Sources & evidence
- ORD record
- ord-781d3af9dc204b3bab01d624ad6f67c2
- Source dataset
- uspto-grants-2016_06
- Patent number
- US09376438B2
Reaction notes
Loading…